Regardless of mechanism, it is clear that antibodies that react with conserved influenza HA/NA epitopes can confer potent antiviral activity in vivo through Fc-FcγR mediated pathways, while strain-specific NAbs cannot engage, nor do they require FcγR interactions for potent protective activity. The gene discussed is FCGR2A; the disease is influenza.